Results 131 to 140 of about 15,983 (179)

AKT Inhibition Sensitizes to Polo-Like Kinase 1 Inhibitor Onvansertib in Prostate Cancer. [PDF]

open access: yesMol Cancer Ther
Nouri M   +8 more
europepmc   +1 more source

Only Infant MLL-Rearranged Leukemia Is Susceptible to an Inhibition of Polo-like Kinase 1 (PLK-1) by Volasertib. [PDF]

open access: yesInt J Mol Sci
Fischer J   +10 more
europepmc   +1 more source

Polo-like Kinase 1 Inhibitors Demonstrate In Vitro and In Vivo Efficacy in Preclinical Models of Small Cell Lung Cancer. [PDF]

open access: yesCancers (Basel)
Zhang G   +9 more
europepmc   +1 more source

SBE13, a newly identified inhibitor of inactive polo-like kinase 1

open access: yesJournal of Cheminformatics, 2010
Keppner Sarah   +3 more
doaj   +1 more source

MYC and HSF1 Cooperate to Drive Sensitivity to Polo-like Kinase 1 Inhibitor Volasertib in High-grade Serous Ovarian Cancer. [PDF]

open access: yesCancer Res Commun
Williams I   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy